Larimar Therapeutics(US:LRMR) Seeking Alpha·2025-09-29 18:55Core Points - The conference call is hosted by Larimar Therapeutics, with a focus on their business and clinical developments [1][2] - A slide deck and a news release are available on the company's website for further information [2] - The call includes forward-looking statements regarding the company's future business expectations, plans for nomlabofusp (formerly CTI-1601), and clinical trials [3] Company Developments - Larimar Therapeutics is discussing the development and commercialization of nomlabofusp, highlighting its significance in their business strategy [3] - The company is expected to provide insights into their planned clinical trials and overall business strategies during the call [3] Financial Position - The conference call will address the company's financial position and results of operations, indicating a focus on capital use and future financial expectations [3]